http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 16 Oct 2026 04:20:20 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/New+Coverage/Goldman+Sachs+Starts+Elanco+Animal+Health+%28ELAN%29+at+Buy/27194879.html <p>Goldman Sachs analyst Matt Dellatorre initiates coverage on Elanco Animal Health (NYSE: ELAN) with a Buy rating and a price target of $32.00.</p> <p>For an analyst ratings summary and ratings history on Elanco Animal Health <a href="http://www.streetinsider.com/rating_history.php?q=ELAN">click here</a>. For more ratings news on Elanco Animal Health <a href="http://www.streetinsider.com/stock_lookup_news.php?q=ELAN&amp;type=analyst">click here</a>.</p> <p>Shares of Elanco Animal Health closed at $23.54 yesterday.</p> http://www.streetinsider.com/New+Coverage/Goldman+Sachs+Starts+Elanco+Animal+Health+%28ELAN%29+at+Buy/27194879.html Fri, 16 Oct 2026 04:20:20 -0400 ELAN http://www.streetinsider.com/SEC+Filings/Form++144++++++++Elanco+Animal+Health+++++++++++++++++++Filed+by%3A+Bettington+Timothy+J/27193279.html si-local-file:///var/storage/secattach/20261015/27193279.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Elanco+Animal+Health+++++++++++++++++++Filed+by%3A+Bettington+Timothy+J/27193279.html Thu, 15 Oct 2026 16:02:00 -0400 ELAN http://www.streetinsider.com/Press+Releases/One+Health+Innovation+District+Breaks+Ground+on+One+Health+Research+Institute%2C+Anchored+by+Purdue+University+and+Elanco+Animal+Health/27159907.html <p><strong id="dateline">INDIANAPOLIS, IN / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / October 7, 2026 / </strong>The One Health Innovation District unveiled plans for the One Health Research Institute, a new hub for research, collaboration and innovation within the District. Anchored by Purdue University and Elanco Animal Health Incorporated (NYSE:ELAN), the Research Institute will accelerate One Health discovery, diagnostics, translational science and commercialization through advanced research, incubator and laboratory space.</p><p>The planned 150,000 square foot, shared-use facility will include advanced research laboratories, shared research infrastructure and equipment and collaboration space, and facilities supporting animal health and veterinary partners. Purdue will http://www.streetinsider.com/Press+Releases/One+Health+Innovation+District+Breaks+Ground+on+One+Health+Research+Institute%2C+Anchored+by+Purdue+University+and+Elanco+Animal+Health/27159907.html Wed, 07 Oct 2026 11:30:00 -0400 ELAN http://www.streetinsider.com/ACCESS+Newswire/One+Health+Innovation+District+Breaks+Ground+on+One+Health+Research+Institute%2C+Anchored+by+Purdue+University+and+Elanco+Animal+Health/27159907.html <p><strong id="dateline">INDIANAPOLIS, IN / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / October 7, 2026 / </strong>The One Health Innovation District unveiled plans for the One Health Research Institute, a new hub for research, collaboration and innovation within the District. Anchored by Purdue University and Elanco Animal Health Incorporated (NYSE:ELAN), the Research Institute will accelerate One Health discovery, diagnostics, translational science and commercialization through advanced research, incubator and laboratory space.</p><p>The planned 150,000 square foot, shared-use facility will include advanced research laboratories, shared research infrastructure and equipment and collaboration space, and facilities supporting animal health and veterinary partners. Purdue will http://www.streetinsider.com/ACCESS+Newswire/One+Health+Innovation+District+Breaks+Ground+on+One+Health+Research+Institute%2C+Anchored+by+Purdue+University+and+Elanco+Animal+Health/27159907.html Wed, 07 Oct 2026 11:30:00 -0400 ELAN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Oct+02++Filed+by%3A+Modi+Rajeev+A./27156051.html si-local-file:///var/storage/secattach/20261006/27156051.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Oct+02++Filed+by%3A+Modi+Rajeev+A./27156051.html Tue, 06 Oct 2026 16:37:00 -0400 ELAN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Oct+02++Filed+by%3A+Simmons+Jeffrey+N/27156048.html si-local-file:///var/storage/secattach/20261006/27156048.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Oct+02++Filed+by%3A+Simmons+Jeffrey+N/27156048.html Tue, 06 Oct 2026 16:37:00 -0400 ELAN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Oct+02++Filed+by%3A+VanHimbergen+Robert+M/27156034.html si-local-file:///var/storage/secattach/20261006/27156034.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Oct+02++Filed+by%3A+VanHimbergen+Robert+M/27156034.html Tue, 06 Oct 2026 16:36:00 -0400 ELAN http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html <p>Investing.com -- Piper Sandler expects veterinary visits to decline 1% to 2% in 2026 and remain roughly flat to down 1% in 2027, with industry growth driven primarily by 3% to 5% pricing increases and limited service-intensity gains.</p><p>The firm noted that the veterinary market remains caught between resilient pricing and weak underlying volumes. Cumulative veterinary inflation since 2022 has likely impacted visits and could continue to affect visits for several more years due to lower puppy growth.</p><p>More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html Tue, 06 Oct 2026 06:38:26 -0400 CHWY ELAN IDXX TRUP TSCO ZTS http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html <p>Investing.com -- Piper Sandler expects veterinary visits to decline 1% to 2% in 2026 and remain roughly flat to down 1% in 2027, with industry growth driven primarily by 3% to 5% pricing increases and limited service-intensity gains.</p><p>The firm noted that the veterinary market remains caught between resilient pricing and weak underlying volumes. Cumulative veterinary inflation since 2022 has likely impacted visits and could continue to affect visits for several more years due to lower puppy growth.</p><p>More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html Tue, 06 Oct 2026 06:38:26 -0400 CHWY ELAN IDXX TRUP TSCO ZTS http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html <p>Investing.com -- Piper Sandler expects veterinary visits to decline 1% to 2% in 2026 and remain roughly flat to down 1% in 2027, with industry growth driven primarily by 3% to 5% pricing increases and limited service-intensity gains.</p><p>The firm noted that the veterinary market remains caught between resilient pricing and weak underlying volumes. Cumulative veterinary inflation since 2022 has likely impacted visits and could continue to affect visits for several more years due to lower puppy growth.</p><p>More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html Tue, 06 Oct 2026 06:38:26 -0400 CHWY ELAN IDXX TRUP TSCO ZTS http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html <p>Investing.com -- Piper Sandler expects veterinary visits to decline 1% to 2% in 2026 and remain roughly flat to down 1% in 2027, with industry growth driven primarily by 3% to 5% pricing increases and limited service-intensity gains.</p><p>The firm noted that the veterinary market remains caught between resilient pricing and weak underlying volumes. Cumulative veterinary inflation since 2022 has likely impacted visits and could continue to affect visits for several more years due to lower puppy growth.</p><p>More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html Tue, 06 Oct 2026 06:38:26 -0400 CHWY ELAN IDXX TRUP TSCO ZTS http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html <p>Investing.com -- Piper Sandler expects veterinary visits to decline 1% to 2% in 2026 and remain roughly flat to down 1% in 2027, with industry growth driven primarily by 3% to 5% pricing increases and limited service-intensity gains.</p><p>The firm noted that the veterinary market remains caught between resilient pricing and weak underlying volumes. Cumulative veterinary inflation since 2022 has likely impacted visits and could continue to affect visits for several more years due to lower puppy growth.</p><p>More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html Tue, 06 Oct 2026 06:38:26 -0400 CHWY ELAN IDXX TRUP TSCO ZTS http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html <p>Investing.com -- Piper Sandler expects veterinary visits to decline 1% to 2% in 2026 and remain roughly flat to down 1% in 2027, with industry growth driven primarily by 3% to 5% pricing increases and limited service-intensity gains.</p><p>The firm noted that the veterinary market remains caught between resilient pricing and weak underlying volumes. Cumulative veterinary inflation since 2022 has likely impacted visits and could continue to affect visits for several more years due to lower puppy growth.</p><p>More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic http://www.streetinsider.com/General+News/Piper+sees+veterinary+medicine+challenges+continuing+through+2027/27151503.html Tue, 06 Oct 2026 06:38:26 -0400 CHWY ELAN IDXX TRUP TSCO ZTS http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+30++Filed+by%3A+Anand+Kapila+K/27135819.html si-local-file:///var/storage/secattach/20261001/27135819.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+30++Filed+by%3A+Anand+Kapila+K/27135819.html Thu, 01 Oct 2026 16:04:00 -0400 ELAN http://www.streetinsider.com/Analyst+Comments/KeyBanc+Reiterates+Overweight+Rating+on+Elanco+Animal+Health+%28ELAN%29/27125967.html <p>KeyBanc analyst Steve Dechert reiterated an Overweight rating and $30.00 price target on Elanco Animal Health (NYSE: ELAN).</p><p>The analyst commented: "We ran a survey in mid-September that went out to 50 vet clinics in the U.S. Responses suggest that broad-spectrum parasiticides remain healthier than derm, with 64% of clinics prescribing more vs. last year. Competitive pressure on ZTS's Simparica Trio appears primarily economic, supporting ZTS's gross-to-net strategy. However, Apoquel faces more clinically driven pressure, while Cytopoint appears more resilient, with affordability the primary concern. For ELAN, Quattro and Zenrelia adoption trends remain strong and are largely efficacy-driven, supporting continued share-gain http://www.streetinsider.com/Analyst+Comments/KeyBanc+Reiterates+Overweight+Rating+on+Elanco+Animal+Health+%28ELAN%29/27125967.html Wed, 30 Sep 2026 08:47:17 -0400 ELAN ZTS http://www.streetinsider.com/Analyst+Comments/KeyBanc+Reiterates+Overweight+Rating+on+Elanco+Animal+Health+%28ELAN%29/27125967.html <p>KeyBanc analyst Steve Dechert reiterated an Overweight rating and $30.00 price target on Elanco Animal Health (NYSE: ELAN).</p><p>The analyst commented: "We ran a survey in mid-September that went out to 50 vet clinics in the U.S. Responses suggest that broad-spectrum parasiticides remain healthier than derm, with 64% of clinics prescribing more vs. last year. Competitive pressure on ZTS's Simparica Trio appears primarily economic, supporting ZTS's gross-to-net strategy. However, Apoquel faces more clinically driven pressure, while Cytopoint appears more resilient, with affordability the primary concern. For ELAN, Quattro and Zenrelia adoption trends remain strong and are largely efficacy-driven, supporting continued share-gain http://www.streetinsider.com/Analyst+Comments/KeyBanc+Reiterates+Overweight+Rating+on+Elanco+Animal+Health+%28ELAN%29/27125967.html Wed, 30 Sep 2026 08:47:17 -0400 ELAN ZTS http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+18++Filed+by%3A+Simmons+Jeffrey+N/27091070.html si-local-file:///var/storage/secattach/20260922/27091070.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+18++Filed+by%3A+Simmons+Jeffrey+N/27091070.html Tue, 22 Sep 2026 16:05:00 -0400 ELAN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+18++Filed+by%3A+Modi+Rajeev+A./27091039.html si-local-file:///var/storage/secattach/20260922/27091039.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+18++Filed+by%3A+Modi+Rajeev+A./27091039.html Tue, 22 Sep 2026 16:05:00 -0400 ELAN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+18++Filed+by%3A+VanHimbergen+Robert+M/27091020.html si-local-file:///var/storage/secattach/20260922/27091020.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Sep+18++Filed+by%3A+VanHimbergen+Robert+M/27091020.html Tue, 22 Sep 2026 16:04:00 -0400 ELAN http://www.streetinsider.com/Analyst+Comments/Elanco+Animal+Health+%28ELAN%29+Reiterated+at+Buy+by+Stifel+on+Befrena+Adoption+Potential/27078280.html <p>Stifel analyst Jonathan Block reiterated a Buy rating and $33.00 price target on Elanco Animal Health (NYSE: ELAN).</p><p>The analyst commented, "For Elanco, Befrena is the standout from the survey. Over 50% of current Cytopoint users expect to adopt Befrena over the NTM, with the majority (~70%) showing a willingness to switch current Cytopoint users. We believe Befrena will contribute 100+ bps to organic growth in 2027 and again in 2028. For Zenrelia, U.S. share gains are moderating (due to Numelvi traction), but in-line with our WW Atopic Dermatitis JAK market model. In 2027, the primary top-line drivers for Elanco are http://www.streetinsider.com/Analyst+Comments/Elanco+Animal+Health+%28ELAN%29+Reiterated+at+Buy+by+Stifel+on+Befrena+Adoption+Potential/27078280.html Fri, 18 Sep 2026 07:55:34 -0400 ELAN http://www.streetinsider.com/Press+Releases/Elanco+to+Participate+in+BofA+Securities+Global+Healthcare+Conference+2026/27072838.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Sept. 17, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) will attend the <span>BofA Securities Global Healthcare Conference</span> 2026 on <chron>September 22, 2026</chron>. <person>Jeff Simmons</person>, president and CEO, will participate in a fireside chat on <chron>Tuesday, September 22</chron> at <chron>2:10 p.m. BST</chron> (<chron>9:10 a.m. EDT</chron>).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Elanco+to+Participate+in+BofA+Securities+Global+Healthcare+Conference+2026/27072838.html Thu, 17 Sep 2026 07:57:00 -0400 ELAN http://www.streetinsider.com/PRNewswire/Elanco+to+Participate+in+BofA+Securities+Global+Healthcare+Conference+2026/27072838.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Sept. 17, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) will attend the <span>BofA Securities Global Healthcare Conference</span> 2026 on <chron>September 22, 2026</chron>. <person>Jeff Simmons</person>, president and CEO, will participate in a fireside chat on <chron>Tuesday, September 22</chron> at <chron>2:10 p.m. BST</chron> (<chron>9:10 a.m. EDT</chron>).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Elanco+to+Participate+in+BofA+Securities+Global+Healthcare+Conference+2026/27072838.html Thu, 17 Sep 2026 07:57:00 -0400 ELAN http://www.streetinsider.com/Options/Elanco+Animal+Health+%28ELAN%29+1875+contracts+of+September+23+calls+trade/27064257.html <p>Elanco Animal Health (NYSE: ELAN) 30-day call option implied volatility is 45; compared to its 52-week range of 34 to 67. Call put ratio 21 calls to 1 put with a focus on 1875 contracts of September 23 calls.</p> http://www.streetinsider.com/Options/Elanco+Animal+Health+%28ELAN%29+1875+contracts+of+September+23+calls+trade/27064257.html Tue, 15 Sep 2026 14:02:11 -0400 ELAN http://www.streetinsider.com/Press+Releases/Expanding+Tick+and+Itch+Season+Supports+Momentum+in+Elanco+Innovation%2C+Meeting+Pet+Owner+Demand+for+Health+and+Wellness+Care/27063700.html <ul><li><i><strong>Innovation that protects against these pests is driving stronger Elanco base business and overall share gains.</strong></i></li><li><i><strong>Elanco confirms U.S. Pet Health is on track to expectations of high-single digit to low double-digit growth in the second half of 2026.</strong></i></li><li><i><strong>U.S. Pet Health price gains have accelerated quarter-to-date vs. Q2.</strong></i></li></ul> <p><strong id="dateline">INDIANAPOLIS, IN / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / September 15, 2026 / </strong>As the calendar turns to fall, Americans expect a seasonal reprieve from ticks and allergies. However, with warming temperatures and expanded pollen seasons we see the parasiticide and dermatology categories shifting toward year-round needs in http://www.streetinsider.com/Press+Releases/Expanding+Tick+and+Itch+Season+Supports+Momentum+in+Elanco+Innovation%2C+Meeting+Pet+Owner+Demand+for+Health+and+Wellness+Care/27063700.html Tue, 15 Sep 2026 12:05:00 -0400 ELAN http://www.streetinsider.com/ACCESS+Newswire/Expanding+Tick+and+Itch+Season+Supports+Momentum+in+Elanco+Innovation%2C+Meeting+Pet+Owner+Demand+for+Health+and+Wellness+Care/27063700.html <ul><li><i><strong>Innovation that protects against these pests is driving stronger Elanco base business and overall share gains.</strong></i></li><li><i><strong>Elanco confirms U.S. Pet Health is on track to expectations of high-single digit to low double-digit growth in the second half of 2026.</strong></i></li><li><i><strong>U.S. Pet Health price gains have accelerated quarter-to-date vs. Q2.</strong></i></li></ul> <p><strong id="dateline">INDIANAPOLIS, IN / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / September 15, 2026 / </strong>As the calendar turns to fall, Americans expect a seasonal reprieve from ticks and allergies. However, with warming temperatures and expanded pollen seasons we see the parasiticide and dermatology categories shifting toward year-round needs in http://www.streetinsider.com/ACCESS+Newswire/Expanding+Tick+and+Itch+Season+Supports+Momentum+in+Elanco+Innovation%2C+Meeting+Pet+Owner+Demand+for+Health+and+Wellness+Care/27063700.html Tue, 15 Sep 2026 12:05:00 -0400 ELAN